Evoq Remedies Limited (BSE: 543500)
Health Care · Health Care Providers & Services · IN
Rs1.82
-5.21% today · -54.3% 1Y
Evoq Remedies Limited (BSE: 543500) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $474.83K.
Over the last twelve months the share price has lost 54.3%, trading between 1.63 and 6.11.
Tweenvest scores Evoq Remedies Limited across four factors: quality 52/100, value 63/100, growth 100/100. Its strongest factor is growth.
543500 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $474.83K
- Revenue (TTM)
- $2.85M
- P/E
- —
- EPS
- -0.10
- Dividend yield
- —
- Beta (5Y)
- 1.42
- 52-week high
- Rs6.11
- 52-week low
- Rs1.63
- Avg volume (3M)
- —
- Shares outstanding
- 24.90M
- Employees
- —
- Next earnings
- —
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $357.92B | $396.59 | -0.54% |
| CVS Health CorporationNYSE: CVS | $120.36B | $92.90 | -1.29% |
| McKesson CorporationNYSE: MCK | $101.88B | $905.09 | +3.58% |
| HCA Healthcare, Inc.NYSE: HCA | $92.93B | $428.76 | -0.11% |
| Elevance Health, Inc.NYSE: ELV | $87.32B | $398.87 | -0.93% |
| The Cigna GroupNYSE: CI | $74.11B | $279.32 | -0.40% |
| Cencora, Inc.NYSE: COR | $61.78B | $328.06 | +1.33% |
| Cardinal Health, Inc.NYSE: CAH | $54.04B | $237.92 | +2.39% |
Figures last refreshed Aug 18, 2026.